Table 4.
Application | Adverse effects | |||||||
---|---|---|---|---|---|---|---|---|
Bisphosphate | ||||||||
Calcium | Vit D | Calcitonin | Bisphosphate | Calcium | Oral | Intravenous injection | ||
Pre-edu | N | 651 | 275 | 64 | 14 | 53 | 19 | 33 |
Percent | 99.7% | 42.1% | 9.8% | 2.1% | 8.1% | 2.9% | 5.1% | |
After-edu | N | 675 | 412 | 88 | 104 | 27 | 24 | 37 |
Percent | 95.2% | 58.1% | 14.0% | 14.7% | 15.8% | 9.4% | 5.2% | |
χ 2 | 26.621 | 34.797 | 25.439 | 67.385 | 19.412 | 17.251 | 0.019 | |
P value | ≤0.001 | ≤0.001 | ≤0.001 | ≤0.001 | 0.001 | 0.006 | 0.890 |
Vit D: vitamin D. P < 0.05 is statistically significant.